Little Yellow Activator

  • Home
  • Little Yellow Activator

Little Yellow Activator Welcome to LifeVantage. Start Small. Dream Big. Life is built on the little things.

20/10/2022

Don't Buy Protandim Until You Watch This Short Video!

Lifevantage is a pioneer Nutrigenomics, dedicated to BIOHACKING the human aging code. Lifevantage is relentless in their...
16/08/2022

Lifevantage is a pioneer Nutrigenomics, dedicated to BIOHACKING the human aging code. Lifevantage is relentless in their commitment to help their customers to live a longer and healthier lives...This video is worth watching
https://youtu.be/D3tciG9Bblc

STORY ON NATIONAL TV. Lifevantage is a pioneer Nutrigenomics, dedicated to BIOHACKING the human aging code. Lifevantage is relentless in their commitment to ...

16/08/2022
https://bit.ly/3pkpDxP
07/08/2022

https://bit.ly/3pkpDxP

The of BACK TO THE OXIDATIVE LEVEL OF A CHILD?Discover the innovative world of Nutrigenomics, and how LifeVantage is using nutrients t...

06/08/2022

A scientific breakthrough the only product that can reduce cell aging in 30 days and increased the median life span by 7%.
Source: National Institute of Aging
Watch this ABC primetime news for more info.
We are also listed in PubMed The National Library of Medicine to gather more information.

Product Testimony on Breast Cancer. Under Chemo for 9 months and 6 weeks Radiotherapy Everyday. Oxidative Stress is Link...
05/08/2022

Product Testimony on Breast Cancer. Under Chemo for 9 months and 6 weeks Radiotherapy Everyday.
Oxidative Stress is Link to Over 200+ Diseases and Our Product Protandim Can Reduced Oxidative Stress by 40% in 30 Days and 70% in 90 Days. Increase Glutathione 300% Catalase 40% and SOD (Super Oxide Dismutase) 30%

*** Disclaimer: We make NO claims to: Treat, cure, prevent or mitigate ANY disease ***
"When our oxidative stress is reduced, our bodies are free to do amazing things!"

Peer-reviewed studies referencing Protandim® Nrf2 Synergizer™LifeVantage is deeply rooted in science. Science is at the ...
03/08/2022

Peer-reviewed studies referencing Protandim® Nrf2 Synergizer™

LifeVantage is deeply rooted in science. Science is at the heart of everything we do. Our flagship product, Protandim®, the Nrf2 Synergizer™, has been validated by peer-reviewed studies conducted in the laboratories of respected universities such as Ohio State University, LSU and the University of Colorado Denver. The results of these studies have been published in mainstream medical journals such as "Free Radical Biology & Medicine" and "Enzyme Research." Below are summaries of these peer-reviewed studies:

Burnham, E. L., et al. (2012). American Journal of Physiology-Lung Cellular and Molecular Physiology
Scalzo, R. L., et al. (2014). The FASEB Journal
Ueberschlag, S. L., et al. (2016). PLoS One
Konopka, A. R., et al. (2017). Geroscience
Velmurugan, K., et al. (2009). Free Radical Biology & Medicine
Liu, J., et al. (2009). PLoS One
Bogaard, H. J., et al. (2009). Circulation
Robbins, D., et al. (2010). PLoS One
Qureshi, M. M., et al. (2010). Journal of Dietary Supplements
Joddar, B., et al. (2011). Free Radical Biology and Medicine
Hybertson, B. M., et al. (2011). Molecular Aspects of Medicine Volume 32
Donovan, E. L., et al. (2012). Oxidative Medicine and Cellular Longevity Volume 2012
Dugan, A., et al. (2012). The FASEB
Reuland, D. J., et al. (2013). Free Radical Biology & Medicine
Lisk, C., et al. (2013). Free Radical Biology & Medicine
Cheatham, M. A., et al. (2015). PLoS ONE
Strong, R. (2016). Aging Cell
Abusarah, J., et al., (2016). The Journal of Cellular Biochemistry
Lim, J. L., et al. (2016). Antioxidants
Chevreau, N., (2017). Federation of American Societies for Experimental Biology
Robbins, D., et al. (2011). SAGE-Hindawi Enzyme Research
Davis, K. (2012). Dental Today
Voelkel, N. F., et al., (2012). Antioxidants & Redox Signaling
Reuland, D. J., et al. (2013). Exercise and Sport Sciences Reviews
Gao, B., et al. (2014). The Journal of Clinical Pharmacology
Pall, M. L. and S. Levine (2015). Sheng Li Xue Bao

03/08/2022
Nrf1 is paved as a new strategic avenue to prevent and treat cancer, neurodegenerative and other diseases.https://pubmed...
03/08/2022

Nrf1 is paved as a new strategic avenue to prevent and treat cancer, neurodegenerative and other diseases.
https://pubmed.ncbi.nlm.nih.gov/30267745/

Transcription factor Nrf1 acts as a unique vital player in maintaining cellular homeostasis and organ integrity during normal development and growth throughout the life process. Loss-of-function of Nrf1 results in severe oxidative stress, genomic instability, embryonic lethality, developmental disor...

02/08/2022
Protandim, a fundamentally new antioxidant approach in chemoprevention using mouse two-stage skin carcinogenesis as a mo...
31/07/2022

Protandim, a fundamentally new antioxidant approach in chemoprevention using mouse two-stage skin carcinogenesis as a model
https://pubmed.ncbi.nlm.nih.gov/19384424/

Oxidative stress is an important contributor to cancer development. Consistent with that, antioxidant enzymes have been demonstrated to suppress tumorigenesis when being elevated both in vitro and in vivo, making induction of these enzymes a more potent approach for cancer prevention. Protandim, a w...

31/07/2022

31/07/2022
Oxidative stress can damage cells, proteins, and DNA, which can contribute to premature aging and health concerns. Prota...
29/07/2022

Oxidative stress can damage cells, proteins, and DNA, which can contribute to premature aging and health concerns. Protandim Nrf2 Synergizer, also known as the Little Yellow Activator, supports the activation of your body’s antioxidant production and has been shown to reduce oxidative stress by 40% in just 30 days.*

LifeVantage’s first Protandim product was the discovery that changed everything. It was––and still is––one of the most groundbreaking insights into reducing oxidative stress.*

Protandim Nrf2 Synergizer quickly drew the attention of both the scientific community and the media. What the product purported to do almost seemed too good to be true. ABC Primetime conducted an investigative report that culminated in the reporter, John Quiñones, performing a blood analysis to test the product on himself. The results of his test showed his oxidative stress dropped 45% in only 2 weeks* and reminded the world what we had known all along…Protandim Nrf2 Synergizer works.

It wasn’t long before over 30 independent researchers, institutions, and universities, such as Harvard University, Colorado State University, Virginia Commonwealth University, Ohio State University, Texas Tech University, the National Institute on Aging, and the American Heart Association, studied and published the validated effects of Protandim Nrf2 Synergizer. To read the research and see what scientists say about this exceptional discovery, go to pubmed.gov and enter the phrases Nrf2 or oxidative stress. It’s that easy.

Protandim Nrf2 Synergizer is so unique and groundbreaking that it is also protected by seven patents. The patents may be found at http://patft.uspto.gov/netahtml/PTO/srchnum.htm by typing in the following patent numbers:

U.S. Patent No. 9,265,808;
U.S. Patent No. 8,435,574;
U.S. Patent No. 8,221,805;
U.S. Patent No. 7,923,045;
U.S. Patent No. 7,579,026;
U.S. Patent No. 7,384,655; and
U.S. Patent No. 7,241,461.
We believe in this groundbreaking product and sharing health and wellness with the world. Please help us share the power of the Little Yellow Tablet.

27/07/2022

Protandim NRF2 question&answer

  CITY
24/07/2022

CITY

Clinical Trials
24/07/2022

Clinical Trials

Address


Alerts

Be the first to know and let us send you an email when Little Yellow Activator posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

  • Want your practice to be the top-listed Clinic?

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram